Procter & Gamble (PG) reported $19.78 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.1%. EPS of $1.54 for the same period compares to $1.52 a year ago.

The reported revenue represents a surprise of -2.75% over the Zacks Consensus Estimate of $20.34 billion. With the consensus EPS estimate being $1.54, the company has not delivered EPS surprise.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how P&G performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Organic Sales Growth (YoY change) - Beauty: 2% versus the six-analyst average estimate of 0.6%.
• Organic Sales Growth (YoY change) - Grooming: 3% versus the six-analyst average estimate of 1.2%.
• Organic Sales Growth (YoY change) - Total P&G: 1% versus the six-analyst average estimate of 1.9%.
• Organic Sales Growth (YoY change) - Baby, Feminine & Family Care: -1% versus 2.2% estimated by six analysts on average.
• Organic Sales Growth (YoY change) - Health Care: 4% compared to the 2% average estimate based on six analysts.
• Net sales- Beauty: $3.49 billion versus the eight-analyst average estimate of $3.52 billion. The reported number represents a year-over-year change of -1.7%.
• Net sales- Grooming: $1.51 billion compared to the $1.53 billion average estimate based on eight analysts. The reported number represents a change of -2.2% year over year.
• Net sales- Corporate: $198 million compared to the $138.87 million average estimate based on eight analysts. The reported number represents a change of +54.7% year over year.
• Net sales- Fabric & Home Care: $6.95 billion versus the eight-analyst average estimate of $7.28 billion. The reported number represents a year-over-year change of -3.1%.
• Net sales- Baby, Feminine & Family Care: $4.76 billion compared to the $5.01 billion average estimate based on eight analysts. The reported number represents a change of -3.7% year over year.
• Net sales- Health Care: $2.88 billion versus the eight-analyst average estimate of $2.91 billion. The reported number represents a year-over-year change of +0.2%.
• Earnings before income taxes- Beauty: $684 million versus $781.26 million estimated by four analysts on average.

View all Key Company Metrics for P&G here>>>

Shares of P&G have returned -0.5% over the past month versus the Zacks S&P 500 composite's -5.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Procter & Gamble Company (The) (PG) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research